about
The crystal structure of the cephalosporin deacetylating enzyme acetyl xylan esterase bound to paraoxon explains the low sensitivity of this serine hydrolase to organophosphate inactivationThe Effect of Regular Intake of Dry-Cured Ham Rich in Bioactive Peptides on Inflammation, Platelet and Monocyte Activation Markers in Humans.Adherence to the "Mediterranean Diet" in Spain and Its Relationship with Cardiovascular Risk (DIMERICA Study).Circulating microparticles: new insights into the biochemical basis of microparticle release and activity.Role of microRNAs in cardiac remodelling: new insights and future perspectives.Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease.Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease.Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes.Characterization of a novel thermostable carboxylesterase from Geobacillus kaustophilus HTA426 shows the existence of a new carboxylesterase family.Characterization of a new rhamnogalacturonan acetyl esterase from Bacillus halodurans C-125 with a new putative carbohydrate binding domain.Improved cross-linked enzyme aggregates for the production of desacetyl beta-lactam antibiotics intermediates.The effects of exercise and diurnal variation on monocyte subsets and monocyte-platelet aggregates.TLR4 expression on monocyte subsets in myocardial infarction.Monocytes circulate in constant reversible interaction with platelets in a [Ca2+]-dependent manner.Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin.Platelet reactivity in prolonged stress disorders--a link with cardiovascular disease?A colorimetric assay for the determination of acetyl xylan esterase or cephalosporin C acetyl esterase activities using 7-amino cephalosporanic acid, cephalosporin C, or acetylated xylan as substrate.Receptors to interleukin-6 and adhesion molecules on circulating monocyte subsets in acute myocardial infarction.An innovative flow cytometric approach for small-size platelet microparticles: influence of calcium.CXCR4 positive and angiogenic monocytes in myocardial infarction.Circulating microparticles: challenges and perspectives of flow cytometric assessmentMonocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysisFibrinolytic status in acute coronary syndromes: Evidence of differences in relation to clinical features and pathophysiological pathwaysGrowth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathyAtorvastatin and its collateral effects on microparticlesImmunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiologyIs plasminogen activator inhibitor-1 (PAI-1) a surrogate marker of vascular damage?Soluble vascular endothelial growth factor receptor (VEGFR)-2 in macular oedema--a mechanism for regulating angiogenesis?Thrombogenesis in lone atrial fibrillation: a role for soluble P-selectin?Multifunctional Peptides from Spanish Dry-Cured Pork Ham: Endothelial Responses and Molecular Modeling StudiesNovel anti-invasive properties of a Fascin1 inhibitor on colorectal cancer cells
P50
Q27666886-EF725DDA-19A4-474F-98F5-E792E1DCAF48Q33616539-F9E6D43E-0C67-4D88-A1FA-AD61E6162933Q37463184-B029F258-0E63-4131-9B84-2FD5CBC0C540Q37892456-1E6865AB-1BFE-4997-89DF-A964462ED5AFQ38051872-FA809896-12C1-472B-BE07-7704C1EE8BF9Q38065252-4FB567DC-4056-41B8-8213-E7A429252D22Q38145381-E05968B3-1FD7-4072-B6C6-05CF8496A481Q39466264-F3D26389-22A1-4F14-BBC3-970FC961722EQ41859264-F8ACBE2E-DAB1-4FF0-86D9-2F92B7D3768FQ41930508-211B92DB-FBAF-4652-B2B9-BB90D1DED88AQ43280536-D01E43B1-C918-4E77-846A-0D10B0B1A767Q44209557-01E27E37-BCF5-47AF-BE76-63DE358AC110Q44629463-E66C7131-2FC2-491C-B903-886333F5E1F7Q46761766-8455C549-7886-4608-8FE9-23A2B07DE5D6Q47174785-F53B48C6-488E-4C1B-B42C-6D92D2CB7A18Q49025410-296CAC64-5F0B-4AB2-8477-B245C1A0B866Q50466862-D5DA54D9-13FA-4AA3-9565-6FD0F76583AAQ50991163-4B98F54F-00CC-4E97-BBD0-8DC628F862B8Q51582978-696929AF-6D4F-47CF-90A9-9ABEDB8163D8Q54466793-22DD0917-B83A-45F7-8811-E07AF651C752Q61845620-5551922C-1EB6-439E-89A4-BDFA8EEAF8FBQ61845631-5805931A-50B2-46E8-8C55-5CB67D52F272Q61845732-873DEB0A-DF56-4DD5-BE61-5E975F417074Q61845744-38725D42-CAB6-4500-AC03-7A1851D5EE3DQ61845769-38201C30-3B37-4CD6-8747-3361CCBE848EQ61845789-82B86B02-9E43-416F-A388-F4CECA65DD4CQ61845802-529BFDDD-8A7A-4985-BA77-E28ECFF8D913Q61845820-738AC00D-F17B-4F63-8EBB-5DF2D2794040Q61845840-A83BE2F3-BD72-4647-A819-B5B48E98BD08Q92987428-1A4FC684-57B8-4D01-A1AC-6DBA3E726258Q93041175-8CB6F06F-6504-4C13-A812-4C6FB05949BC
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Silvia Montoro-García
@ast
Silvia Montoro-García
@en
Silvia Montoro-García
@es
Silvia Montoro-García
@nl
Silvia Montoro-García
@sl
type
label
Silvia Montoro-García
@ast
Silvia Montoro-García
@en
Silvia Montoro-García
@es
Silvia Montoro-García
@nl
Silvia Montoro-García
@sl
prefLabel
Silvia Montoro-García
@ast
Silvia Montoro-García
@en
Silvia Montoro-García
@es
Silvia Montoro-García
@nl
Silvia Montoro-García
@sl
P1053
K-8101-2014
P106
P21
P31
P3829
P496
0000-0002-1948-1022